(R)-5-(HYDROXYMETHYL)-3-METHYLOXAZOLIDIN-2-ONE, 95.0%, 1g

5-Ethynyl-dUTP, min. 95%, 100 mM in water, 50 µl, plastic packaging.

6-Cyano-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-(pentan-3-yl)-1H-indole-4-carboxamide, 98%, 50mg

Methyl-(E)-3-fluorocinnamate, 98.0%, 1g

2-Iminothiolane hydrochloride, 97.0%, 500mg

1-(4,4-DIFLUOROCYCLOHEXYL)ETHANONE, 95.0%, 250mg

Ethyl 2-(pyridin-2-ylsulfanyl)acetate, 97.0%, 250mg

4,5-Dibromo-2-methylaniline, 1g

N-(4-(N-(5-Methylisoxazol-3-yl)sulfamoyl)phenyl)acetamide, 95.0%, 5g

tert-Butyl 3,9-diazabicyclo[3.3.1]nonane-3-carboxylate, 97%, 100mg

1-(3-Bromophenyl)-N-methylmethanamine hydrochloride, 95.0%, 10g

2-(4-Bromo-phenyl)quinoline-4-carboxylic acid, 95.0%, 1g

2-Bromo-3-(trifluoromethyl)aniline, 98.0%, 100g